RCE recce pharmaceuticals ltd

3.23%

30.0¢

[WEBINAR REPLAY] What it takes to get a new drug to market in Australia, page-6

First 6 Last

Share
Profile

Follow
andrewk65

5,482 Posts.

705

29/05/24

13:43

Post #: 74064018
Share

Originally posted by andrewk65: ↑

I don't know for sure but i can only guess maybe the plan is to get some sort of approval for a product that can be sold in Indo and generate some income.

Regardless of how valuable we may think this approach is. It is fairly evident that the previous big CR amount of around 26 million was drained just achieving in Human safety data and some phase 1 progress. Then another 12 million that looks like it is disappearing quickly too to get to current stage. They desperately need to generate some income from somewhere i would think otherwise further dilution for all including the directors is inevitable.

Seems one can consider this akin to mining with the question "Is it a duster?". We just have to decide do we believe this product can ultimately work or is it some sort of hoax?

For me, there seem to be too many emergency access stories and early trial results to think it doesn't work. It just seems the difficulty is figuring the best application and dose. The difficulty seems to be internal application doesn't quite do what we expected so changes were made. External application also it appears had to be adjusted on the run due to results achieved? Either way it is all progress.

The timelines don't seem unusual for a "Normal" drug development approval path, maybe the incredible fast approvals for covid vaks gave everyone a false sense of how long it takes?

From a chart point of view it is certainly looking IMO like it has finally bottomed out and may be reversing? Could even call it a cup and handle forming now??

Expand

Cup and handle/ double bottom normally a good thing i believe? Especially after a multi year down trend? If it can get back up to around 70c levels and complete the handle it might be on for all?

Last edited by andrewk65: 29/05/24

RCE Price at posting: 59.5¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 6 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.0¢		Change -0.010(3.23%)		Mkt cap ! $86.51M

Open	High	Low	Value	Volume
30.5¢	32.0¢	30.0¢	$25.37K	83.18K

Buyers (Bids)

No.	Vol.	Price($)
1	4552	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	1634	7

View Market Depth

No.	Vol.	Price($)
1	4552	0.300
7	137175	0.295
3	13698	0.290
4	213518	0.285
12	346389	0.280

Price($)	Vol.	No.
0.305	1634	7
0.310	2180	2
0.315	24089	2
0.320	15000	1
0.330	114230	1

Last trade - 12.26pm 26/06/2025 (20 minute delay)

RCE (ASX) Chart

[WEBINAR REPLAY] What it takes to get a new drug to market in Australia, page-6

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

[WEBINAR REPLAY] What it takes to get a new drug to market in Australia, page-6

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News